Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV001290489 | SCV001478527 | pathogenic | Glanzmann thrombasthenia | 2020-09-08 | reviewed by expert panel | curation | The ITGA2B nonsense variant NM_000419.4:c.531T>A (p.Cys177Ter) introduces a premature termination codon and the resulting mRNA product is predicted to undergo nonsense mediated decay, leading to loss of normal protein function. This variant has been observed in heterozygosity in a proband with a phenotype specific for Glanzmann's thrombasthenia (GT) and in homozygosity in an additional individual with GT. This variant has not been reported in population databases. In summary, this variant meets criteria to be classified as pathogenic for GT. GT-specific criteria applied: PVS1, PM2_supporting, PM3_supporting, and PP4_moderate. |